Surgical oncology is one of the integrated disciplines of the oncology service at Colorado State University. Research in this discipline involves retrospective studies, in vitro laboratory experiments, and clinical trials with client-consent. Many facets have been investigated (for the benefit of animal wellness and for improving human health), and our surgical oncologists collaborate with their colleagues from the other disciplines and from human medicine to make this a true integrated and translational approach.
About Dr. Janssens
Dr. Brandan Janssens received his BVSc (DVM equivalent) degree from the University of Pretoria, South Africa. After spending two years in general practice in South Africa, he completed a rotating internship at the University of Liverpool in the UK. After his intern year, he stayed on as a research assistant in the Musculoskeletal Biology group and then completed a Small Animal Surgical residency. After a brief time on the faculty at the University of Liverpool as a soft tissue surgeon, Dr. Janssens completed a surgical oncology fellowship at Colorado State University. Dr. Janssens joined Texas A&M University as faculty in 2017 and returned to Colorado State University in 2020. He is currently an Assistant Professor of Surgical Oncology. His research interests are varied but he has a particular interest in sarcomas and investigating epigenetic drivers of a subtype of sarcoma that develops in people and dogs.
About Dr. Worley
Dr. Deanna Worley received her D.V.M. from Colorado State University in 1999. Following that time, she completed a small animal internship, spent two years as a general practitioner, and two years in a small animal surgical internship. In 2007, she completed a surgery residency at the University of Pennsylvania and then returned to CSU as a surgical oncology fellow and joined the faculty in 2008. Her research interests include defining lymphatic circulation and physiology as it relates to cancer treatment and metastasis, particularly tumor-induced lymphangiogenesis and lymphatic-targeting chemotherapy, and in lessening surgical trauma associated with cancer treatment.